Cosmetic cross-reference Noindex: medium evidence

Oils, caraway

CAS 8000-42-8

Oils, caraway (CAS 8000-42-8) is a pharmaceutical compound with 0 bioactivity targets and 12 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral
Adverse signals
12
SOURCE IUPHAR/BPS
PubMed IDs
0
SOURCE EPA DSSTox

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
Oils, caraway
CAS Number
8000-42-8
Source Match
EPA DSSTox
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE DSSTox identifiers DTXSID501009816

Cross-Reference to Chemicals

Same-CAS substance identity is available in the industrial chemicals vertical.

Oils, caraway is linked to DTXSID501009816 in DSSTox identifiers.

View industrial chemical data →
SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is Oils, caraway used for in pharmaceutical contexts?

Oils, caraway (CAS 8000-42-8) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for Oils, caraway?

Oils, caraway has 12 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Back pain, Blister, Blood creatinine increased, Diarrhoea, Fatigue. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is Oils, caraway also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Carum Carvi Fruit Oil with EU status "permitted".

What clinical phase is Oils, caraway in?

No phase 1-4 clinical development badge is rendered for Oils, caraway because the matched compound identifier rows do not contain a max-phase value.